selected publications
- A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution. European urology oncology. 2025 Academic Article GET IT
-
Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease.
Radiation oncology (London, England).
2025
Academic Article
GET IT
Times cited: 1 - Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE). BMC urology. 2024 Academic Article GET IT
- Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study. JCO precision oncology. 2024 Academic Article GET IT
-
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.
International journal of radiation oncology, biology, physics.
2024
Review
GET IT
Times cited: 11 - Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer. JAMA network open. 2023 Academic Article GET IT
- A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT). BMC cancer. 2023 Academic Article GET IT
- Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). BMC cancer. 2023 Academic Article GET IT
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Oncoimmunology.
2023
Review
GET IT
Times cited: 10 -
Image-guided radiation therapy of tumors in preclinical models.
Methods in cell biology.
2023
Academic Article
GET IT
Times cited: 1 - Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2023 Academic Article GET IT
- Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2023 Editorial Article GET IT
-
Radiation therapy: An old dog learning new tricks.
Methods in cell biology.
2022
Editorial Article
GET IT
Times cited: 1 -
Parallels Between the Antiviral State and the Irradiated State.
Journal of the National Cancer Institute.
2021
Academic Article
GET IT
Times cited: 6 -
The role of dendritic cells in cancer and anti-tumor immunity.
Seminars in immunology.
2021
Review
GET IT
Times cited: 188 -
Radiation Therapy and the In Situ Vaccination Approach.
International journal of radiation oncology, biology, physics.
2020
Review
GET IT
Times cited: 67 -
Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer.
Advances in radiation oncology.
2020
Academic Article
GET IT
Times cited: 8 -
CDK12 Gene Alterations in Prostate Cancer: Present, but Clinically Actionable?.
European urology.
2020
Editorial Article
GET IT
Times cited: 1 -
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.
World neurosurgery.
2019
Academic Article
GET IT
Times cited: 5 -
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
International journal of radiation oncology, biology, physics.
2019
Review
GET IT
Times cited: 67 -
Role of noninvasive molecular imaging in determining response.
Advances in radiation oncology.
2018
Review
GET IT
Times cited: 24 -
Avelumab: is it time to get excited?.
Expert review of anticancer therapy.
2018
Editorial Article
GET IT
Times cited: 5 -
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 267 -
The Winds of Change: Emerging Therapeutics in Prostate Cancer.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2018
Review
GET IT
Times cited: 3 -
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.
Urologic oncology.
2018
Academic Article
GET IT
Times cited: 10 -
Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Current treatment options in oncology.
2018
Review
GET IT
Times cited: 6 -
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
Cancer immunology research.
2018
Academic Article
GET IT
Times cited: 72 -
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.
Journal for immunotherapy of cancer.
2018
Conference Paper
GET IT
Times cited: 23 -
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
International journal of radiation oncology, biology, physics.
2017
Academic Article
GET IT
Times cited: 279 -
Avelumab demonstrates promise in advanced NSCLC.
Oncotarget.
2017
Editorial Article
GET IT
Times cited: 5 -
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Cancer immunology research.
2017
Academic Article
GET IT
Times cited: 177 -
Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.
Frontiers in oncology.
2017
Academic Article
GET IT
Times cited: 26 -
Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study.
Neurosurgery.
2017
Academic Article
GET IT
Times cited: 9 -
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.
Frontiers in oncology.
2017
Academic Article
GET IT
Times cited: 7 -
LAG3 (CD223) as a cancer immunotherapy target.
Immunological reviews.
2017
Review
GET IT
Times cited: 738 -
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.
Neuro-oncology.
2015
Academic Article
GET IT
Times cited: 107 -
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
Journal of neurosurgery.
2015
Academic Article
GET IT
Times cited: 84 -
3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.
European radiology.
2015
Academic Article
GET IT
Times cited: 14 -
Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature.
Case reports in oncological medicine.
2015
Academic Article
GET IT
Times cited: 11 -
Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).
Growth factors (Chur, Switzerland).
2015
Academic Article
GET IT
Times cited: 12 -
Stereotactic body radiation therapy in pancreatic cancer: the new frontier.
Expert review of anticancer therapy.
2014
Review
GET IT
Times cited: 25 - Torus palatinus. 2014 GET IT
-
Is there a role for an external beam boost in cervical cancer radiotherapy?.
Frontiers in oncology.
2013
Academic Article
GET IT
Times cited: 16 -
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Cancer research.
2012
Academic Article
GET IT
Times cited: 212 -
Introduction to the medical professions through an innovative medical student-run pipeline program.
Journal of the National Medical Association.
2011
Academic Article
GET IT
Times cited: 16